Aimmune Therapeutics (AIMT) Short Interest Ratio & Short Volume → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free AIMT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Aimmune Therapeutics Short Interest DataCurrent Short Volume4,180,000 sharesPrevious Short Volume6,740,000 sharesChange Vs. Previous Month-37.98%Dollar Volume Sold Short$144.00 millionShort Interest Ratio / Days to Cover1.9Last Record DateSeptember 30, 2020Outstanding Shares65,450,000 sharesFloat Size51,820,000 sharesShort Percent of Float8.07%Today's Trading Volume0 sharesAverage Trading Volume1,714,599 sharesToday's Volume Vs. Average0% Short Selling Aimmune Therapeutics ? Sign up to receive the latest short interest report for Aimmune Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAIMT Short Interest Over TimeAIMT Days to Cover Over TimeAIMT Percentage of Float Shorted Over Time Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Aimmune Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20204,180,000 shares $144.00 million -38.0%8.1%1.9 $34.45 9/15/20206,740,000 shares $231.25 million -62.2%14.7%3.2 $34.31 8/31/202017,850,000 shares $610.83 million -3.1%38.9%8.8 $34.22 8/14/202018,420,000 shares $251.43 million -1.9%40.2%16.9 $13.65 7/31/202018,770,000 shares $247.95 million +2.5%40.9%16.5 $13.21 7/15/202018,310,000 shares $292.04 million -3.4%40.0%16.4 $15.95 Get the Latest News and Ratings for AIMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/30/202018,960,000 shares $316.82 million +5.2%42.6%16.2 $16.71 6/15/202018,030,000 shares $335.54 million +0.6%40.5%14.5 $18.61 5/29/202017,920,000 shares $297.65 million -1.5%40.3%12.9 $16.61 5/15/202018,200,000 shares $297.39 million +3.3%40.9%12.6 $16.34 4/30/202017,620,000 shares $301.65 million +6.5%39.4%11.7 $17.12 4/15/202016,550,000 shares $258.35 million +7.0%37.0%9.1 $15.61 3/31/202015,470,000 shares $223.08 million +8.9%35.2%8.4 $14.42 3/13/202014,208,700 shares $212.85 million -6.2%32.6%11 $14.98 2/28/202015,150,000 shares $360.72 million +3.8%34.7%10.3 $23.81 2/14/202014,600,000 shares $408.36 million +21.8%34.5%10.8 $27.97 1/31/202011,990,000 shares $372.29 million +3.6%28.2%9.4 $31.05 1/15/202011,570,000 shares $409.23 million +6.4%29.0%13 $35.37 12/31/201910,870,000 shares $363.82 million -1.0%27.3%13.4 $33.47 8/15/201910,746,000 shares $235.34 million +2.3%31.4%20.8 $21.90 AIMT Short Interest - Frequently Asked Questions What is Aimmune Therapeutics' current short interest? Short interest is the volume of Aimmune Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 4,180,000 shares of AIMT short. 8.07% of Aimmune Therapeutics' shares are currently sold short. Learn More on Aimmune Therapeutics' current short interest. What is a good short interest ratio for Aimmune Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AIMT shares currently have a short interest ratio of 2.0. Learn More on Aimmune Therapeutics's short interest ratio. What is a good short interest percentage for Aimmune Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.07% of Aimmune Therapeutics' floating shares are currently sold short. Is Aimmune Therapeutics' short interest increasing or decreasing? Aimmune Therapeutics saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 4,180,000 shares, a drop of 38.0% from the previous total of 6,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aimmune Therapeutics' float size? Aimmune Therapeutics currently has issued a total of 65,450,000 shares. Some of Aimmune Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aimmune Therapeutics currently has a public float of 51,820,000 shares. How does Aimmune Therapeutics' short interest compare to its competitors? 8.07% of Aimmune Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aimmune Therapeutics: Arvinas, Inc. (12.59%), Rhythm Pharmaceuticals, Inc. (16.20%), Vera Therapeutics, Inc. (16.12%), Rocket Pharmaceuticals, Inc. (11.62%), TG Therapeutics, Inc. (24.66%), Merus (5.86%), Dyne Therapeutics, Inc. (16.19%), Corcept Therapeutics Incorporated (23.90%), Keros Therapeutics, Inc. (5.82%), Maravai LifeSciences Holdings, Inc. (4.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.91 billion), Aon plc ($3.68 billion), The Clorox Company ($2.92 billion), Analog Devices, Inc. ($2.35 billion), Uber Technologies, Inc. ($2.27 billion), Moderna, Inc. ($2.14 billion), The Kroger Co. ($2.14 billion), Datadog, Inc. ($2.00 billion), Simon Property Group, Inc. ($1.85 billion), and International Flavors & Fragrances Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Aimmune Therapeutics stock? Short selling AIMT is an investing strategy that aims to generate trading profit from Aimmune Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aimmune Therapeutics? A short squeeze for Aimmune Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AIMT, which in turn drives the price of the stock up even further. How often is Aimmune Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AIMT, twice per month. The most recent reporting period available is September, 30 2020. More Short Interest Resources from MarketBeat Related Companies: ARVN Short Interest RYTM Short Interest VERA Short Interest RCKT Short Interest TGTX Short Interest MRUS Short Interest DYN Short Interest CORT Short Interest KROS Short Interest MRVI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AIMT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersIs Tesla going out of business?DTIMan Who Predicted 2008: “This Will be Worse.”Altimetry